Oncology EHR Market: Best of Breed Still Lead, Epic and Cerner Make Inroads

Specialty or “best-of-breed” electronic health record vendors in the oncology market continue to dominate, though enterprise vendors are beginning to make headway, according to research from KLAS.

Advertisement

Best-of-breed vendors like Elekta and Varian continue to command a large market share as they provide the needed functionalities while catering specifically to oncology. However, enterprise vendors like Cerner and Epic are beginning to increase their presence in the marketplace. Another vendor to watch is McKesson, which is poised to significantly increase its market share following the acquisition of US Oncology and iKnowMed.

“The best-of-breed vendors have had to tighten up their interfacing capabilities to prove that they can compete with the enterprise vendors,” said report author Monique Rasband in the news release. “However, with only 67 percent of providers in the study attesting for meaningful use, it is clear that there is a lot of room for growth and support from all oncology vendors.”

More Articles on EHRs:

The Top 3 EHRs Used by Mid-Sized Practices
ONC: Physician EHR Adoption is On Track
Taking Medication Automation One Step Further With EMR Interoperability

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The hidden cost of lost clinical time and how leading health systems are responding

Friday, August 7
12:00 PM - 1:00 PM CDT

Presenters: Kassaundra McKnight-Young, Zebra TechnologiesGregory Carras, Zebra TechnologiesJennifer Gene, Levata

Advertisement

Next Up in Health IT

Advertisement

Comments are closed.